5Parlier V,van Melle G, Beris P, et al. Prediction of 18-monthsurvival in patients with primary myelodysplastic syndrome.Aregression model and scoring system based on the combination ofchromosome findings and the Bournemouth score [ J ] . Cancer GenetCytogenet, 1995,81(2): 158-165.
6Sol6 F, Espinet B, Woessner S, et al. Incidence, characterization andprognostic significance of chromosomal abnormalities in 640 patientswith primary myelodysplastic syndromes. Grupo Cooperative) Espaiiolde Citogen6tica Hematol6gica [ J ]. Br J Haematol,2000, 108 ( 2 ):346-356.
二级参考文献11
1Third mic cooperative study group. Morphologic, immu- nologic and cytogenetic (MIC)working classification of the primacy myelodysplastic syndrome and therapy-relat- ed myelodysplasias and leukeanias[J]. Cancer C-enet Cy- togenet, 1998,32 : 1 10.
2GHADDAR H M,STASS S A,PIERCE S,el al. Cytoge nctic evolution following the transformation of myclodys plastic syndrome to acute myelogenous leukemia: hnplica tions on the overlap between the two diseases[J]. I.euke mia, 1994,8 : 1649-- 1653.
3BAIN B J. Di Guglielmo and his syndromes[J]. Br J Haemalol, 2003,120 = 939 -- 9,:13.
4MAZZEI.I.A F M,KOWAL VERN A.SHRIT M A,et al. Acute erythroleukemia: evaluation of 48 cases with reference to classification, cell proliferation, cytogenetics, and prognosis[J]. Am J Clin Pathol, 1998, 110: 590-- 598.
5K()WAI. VERN A,COTELINGAM J, SCHUMACHER H R. The prognostic significance of proerythroblasts in a- cute erythroleukemia[J]. Am J Clin Pathol, 1992,98:34 - 40.
6C-ARAND R, DUCHAYNE E, BLANCHARD D, et al. Minimally differentiated erythroleukaemia(AMI. M6 'va riant')., a rare subset of AMI. distinct from AMI. M6. Groupe Francais d" Hamatologie ('ellulaire [J ]. tr J Haematol, 1995,90 . 868 -- 875.
7SWERDLOW S It, CAMPO E, HARRIS N I., et al. WHO Classification of Tumours of Haematopoietic and I.ymphoid Tissues[M]. Lyon, France: IARC, 2008 : 88 -- 98.
8BACHER U, HAFERLACH C, ALPERMANN T,et al. Comparison of genetic and clinical aspects in patients with acule myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells[J]: Haematologica,2011,96 -- 96.
9LIU W, HASSEP, JIAN R P, HU Y, et al. Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization elassification[J]. Mod Pathol. 2011,24:375 383.
10MARCUCCI G, MAHARRY K,WHITMAN S P, et al. High expression levels of the ETSrelated gcne, ERG, predict adverse outcome and improve molecular risk based classification of cytc genetically normal acute myeloid leukemia:a Cancer and Leukemia Group B Study[J]. J Clin 0ncol,2007,25:3337 3343.
